People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Other, Biotech, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trion Worlds Inc | — | Other | Series C | $85.1M | $1.5B | 2012 |
| Cyrus Biotechnology, Inc. | — | Biotech | Series B | $37.4M | $5.2M | 2017 |
| Health Rhythms Inc. | — | Healthtech | Series B | $19.4M | $217.7M | 2022 |
| New Engen, Inc. | — | Other Technology | Series A | $10.6M | $223.6M | 2016 |
Gus Tai at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gus Tai on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nate Redmond | 1 | 15 |
| Jason Smith | 1 | 14 |
| Eric Carlborg | 1 | 14 |
| Chad Waite | 1 | 11 |
| Eric Bell | 1 | 7 |
| Seth Feuerstein | 1 | 4 |
| John Chuang | 1 | 3 |
| MARK BENJAMIN | 1 | 3 |
| David Atchison | 1 | 3 |
| Richard Zane | 1 | 3 |
| Sunny Kumar | 1 | 3 |
| Paul Gilbert | 1 | 3 |
| Ramakrishna Satyavolu | 1 | 2 |
| Javier Castellanos | 1 | 2 |
| Nivon Lucas | 1 | 1 |
| Lucas Nivon | 1 | 1 |
| Pete Moran | 1 | 1 |
| Malcolm Dunne | 1 | 1 |
| Lars Buttler | 1 | 1 |
| Yifan Song | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.